Segment Reporting

6 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Segment Reporting

19. Segment Reporting

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

The Company manages and aggregates its operational and financial information in accordance with two reportable segments: Rx and Consumer Health. The Rx segment consists of the Company’s prescription products. The Consumer Health segment contains the Company’s consumer healthcare products.

Select financial information for these segments is as follows:

	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2022		2021		2022		2021
	(In thousands)
Consolidated revenue:
Rx Segment	$	18,029	$	14,643	$	36,681	$	28,526
Consumer Health Segment		8,250		8,482		17,253		16,496
Consolidated revenue	$	26,279	$	23,125	$	53,934	$	45,022
Consolidated net loss:
Rx Segment	$	(5,280)	$	(9,591)	$	(5,154)	$	(36,048)
Consumer Health Segment		(1,413)		(1,957)		(2,240)		(3,351)
Consolidated net loss	$	(6,693)	$	(11,548)	$	(7,394)	$	(39,399)

	December 31,		June 30,
	2022		2022
	(In thousands)
Total assets:
Rx Segment	$	125,419	$	121,377
Consumer Health Segment		16,017		16,246
Consolidated assets	$	141,436	$	137,623